Capacity of continuous dialysis therapies in Peru for COVID-19 patients with acute kidney injury
Keywords:
COVID-19, SARS-CoV-2, prevalence, renal dialysis, acute kidney injury
References
1) Claure-Del Granado R, Casas-Aparicio G, Rosa-Diez G, Rizo-Topete L, Ponce D. Renal replacement therapy for acute kidney injury in COVID-19 patients in Latin America. Kidney Blood Press Res. 2020;45(6):775-83. doi: 10.1159/000511914.
2) Benites-Flores IR, Valdivia-Vega RP, Alcalde-Ruiz SF, Espinoza-Rojas HJ. Clinical characteristics of acute kidney injury in the first 13 critically ill patients infected with SARS-CoV-2 at a Peruvian hospital: a preliminary report. J Nephropathol. 2021;10(2):e15. doi: 10.34172/jnp.2021.15.
3) Nash DM, Przech S, Wald R, O'Reilly D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017;41:138-44. doi: 10.1016/j.jcrc.2017.05.002.
4) Reddy YNV, Walensky RP, Mendu ML, Green N, Reddy KP. Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States. Am J Kidney Dis. 2020;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005.
5) Perú. Ministerio de Salud. Sala situacional COVID-19 Perú [Internet]. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp (consulta: 23/11/2020).
6) Herrera-Añazco P, Atamari-Anahui N, Flores-Benites V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Perú Med Exp Salud Pública. 2019;36(1):62-7. doi: 10.17843/rpmesp.2019.361.4253.
2) Benites-Flores IR, Valdivia-Vega RP, Alcalde-Ruiz SF, Espinoza-Rojas HJ. Clinical characteristics of acute kidney injury in the first 13 critically ill patients infected with SARS-CoV-2 at a Peruvian hospital: a preliminary report. J Nephropathol. 2021;10(2):e15. doi: 10.34172/jnp.2021.15.
3) Nash DM, Przech S, Wald R, O'Reilly D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care. 2017;41:138-44. doi: 10.1016/j.jcrc.2017.05.002.
4) Reddy YNV, Walensky RP, Mendu ML, Green N, Reddy KP. Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States. Am J Kidney Dis. 2020;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005.
5) Perú. Ministerio de Salud. Sala situacional COVID-19 Perú [Internet]. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp (consulta: 23/11/2020).
6) Herrera-Añazco P, Atamari-Anahui N, Flores-Benites V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Perú Med Exp Salud Pública. 2019;36(1):62-7. doi: 10.17843/rpmesp.2019.361.4253.
Published
2021-12-07
How to Cite
1.
Herrera-Añazco P, León-Rabanal C, Valdivia-Vega RP. Capacity of continuous dialysis therapies in Peru for COVID-19 patients with acute kidney injury. Rev Nefrol Dial Traspl. [Internet]. 2021Dec.7 [cited 2024Dec.27];41(4):311-2. Available from: http://vps-1689312-x.dattaweb.com/index.php/rndt/article/view/722
Section
Letter to the Editor
Copyright (c) 2021 Revista de Nefrología, Diálisis y Trasplante
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
